Clinical Trials Directory

Trials / Conditions / Human Papilloma Virus

Human Papilloma Virus

133 registered clinical trials studyying Human Papilloma Virus26 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingManaging Hepatitis B (Hep. B) and Human Papilloma Virus (HPV) Related Cancers and Mental Health.
NCT06786429
Eunice DubePhase 4
Not Yet RecruitingTheraT® Vectors (Vaccines) Combined With Chemotherapy to Treat HPV16 Head and Neck Cancers
NCT05108870
University of ChicagoPhase 1 / Phase 2
Not Yet RecruitingBlood Biomarkers Based Screening for HPV-driven OPC
NCT06528353
UNICANCERN/A
CompletedMobile App-Supported HPV and Breast Cancer Awareness Program
NCT07471113
Ataturk UniversityN/A
Not Yet RecruitingUse of ACU-D1 in HPV Associated Vulvar and Perianal Lesions in People With HIV
NCT06233331
Emory UniversityPhase 1
RecruitingPopSci CHW4CervixHealth
NCT07336134
Thomas Jefferson UniversityN/A
RecruitingMerck IIT: RRP Pembro and Lenvatinib
NCT04645602
Yale UniversityEARLY_Phase 1
RecruitingHPV Equity Study: Exploring Cervical Cancer Control in Scotland for Women With Experience of Priority Risks
NCT06414057
University of Edinburgh
RecruitingIntratumoral Lidocaine Injection Before Oropharyngeal Cancer Surgery
NCT06747390
Ryan CareyPhase 1
Not Yet RecruitingAutologous T Cells Targeting HPV16 HPV18 & Survivin in Patients With R/R HPV-related Oropharyngeal Cancers
NCT05582590
NexImmune Inc.Phase 1
RecruitingEvaluating Gardasil HPV Vaccine Humoral and Cellular Immune Responses in People With and Without HIV
NCT06624839
University of Maryland, BaltimorePhase 2
TerminatedConversational Agents to Improve HPV Vaccine Acceptance in Primary Care (ECA-HPV)- Clinical Trial
NCT06367699
Tufts Medical CenterN/A
Active Not RecruitingEfficacy of Human Papillomavirus (HPV) Vaccination to Prevent Infection Among Women Living With HIV.
NCT06436274
Massachusetts General HospitalPhase 4
TerminatedDeveloping and Evaluating a Novel Approach to Improve HPV Vaccination Coverage Among High-risk, Under-immunize
NCT06229353
University of Alabama at Birmingham
RecruitingHigh Resolution Anuscopy Study
NCT06697964
Universitair Ziekenhuis Brussel
RecruitingDeveloping a Combined Molecular Screening and Triage Test for Cervical Cancer in Self-samples
NCT06598176
Universiteit AntwerpenN/A
UnknownPrevalence of HPV (Human Papilloma Virus) and HPV Vaccination Among Victims of Sexual Violence
NCT06255938
Centre Hospitalier Universitaire Saint Pierre
CompletedScreening With Tampons: Evaluating Diagnostic Accuracy and HPV and Assessing Participant Views
NCT06154239
Anne's Day LtdN/A
CompletedPromise Women Project
NCT05862844
Mark Dignan, PhDN/A
RecruitingPrevention of Cervical Cancer Using the Genotyping Screening and Same-day Self-sampling
NCT07232355
Atila Biosystems Inc.
RecruitingA Study of Reduced Dosing of the Nonavalent HPV Vaccine in Women Living With HIV
NCT05495906
University of British ColumbiaPhase 4
RecruitingMultidimensional and Multimodal Profiling of Oropharyngeal Carcinoma
NCT05880797
Stanford University
UnknownCarrageenan for the Prevention of Oral HPV Infection
NCT05746988
McGill UniversityN/A
Active Not RecruitingCervical Cancer Screening Based on First-void Urine Self-sampling to Reach un(Der)-Screened Women: ScreenUrSel
NCT05996783
Universiteit AntwerpenN/A
RecruitingAdvancing HPV Vaccination Among HIV Positive Adults: The CHAMPS Study
NCT05065840
Emory UniversityN/A
CompletedDry Run of the ScreenUrSelf Trial
NCT05996796
Universiteit AntwerpenN/A
UnknownThe Prevalence of Oral HPV Infection and Oral Lesions in People Living With HIV
NCT06205511
Vivent Health
CompletedEngaging Clinical Champions to Improve HPV Vaccination
NCT05736718
UNC Lineberger Comprehensive Cancer CenterN/A
Active Not RecruitingImpact of Financial Incentives
NCT05744960
UNC Lineberger Comprehensive Cancer CenterN/A
Active Not RecruitingImpact of Standing Orders Optimization
NCT05742386
UNC Lineberger Comprehensive Cancer CenterN/A
Active Not RecruitingSingle Visit Clinical Validation of ScreenFire, a Low-cost HPV Test
NCT05431699
The Cleveland ClinicN/A
CompletedDetection and Prevalence of Human Papillomavirus (HPV) in Seminal Plasma and/or on Sperm in Men Undergoing Tre
NCT06161727
Vastra Gotaland Region
CompletedPatient Self-sampling of HPV to Screen for Cervical Cancer
NCT05600283
Mayo ClinicN/A
RecruitingVaginal Microbiome and HPV Pre-malignant and Cervical Dysplasia
NCT05640700
Hadassah Medical Organization
CompletedEducational Video's Impact on Knowledge Regarding Cervical Cancer Screening
NCT05756192
George Washington UniversityN/A
Active Not RecruitingImmunogenicity of the 9vHPV Vaccination 2-dose Regimen Among Children 4 to 8 Years Old
NCT05329961
Boston Medical CenterEARLY_Phase 1
RecruitingAnal Follow-up of Patients With a Gynecological History of High-grade Lesion and More Induced HPV
NCT05566106
Fondation Hôpital Saint-Joseph
Not Yet RecruitingHPV-SAVE_Merck_Sub-Study for Preventing Recurrence of HSIL
NCT03947775
University Health Network, TorontoPhase 2
UnknownAnal Cancer Risk In Women
NCT05835947
Imperial College London
Active Not RecruitingDevelopment of a Self-collection Device for Cervical Cancer Screening
NCT05669911
Teal Health, Inc.N/A
RecruitingA Study of Reduced Radiation Therapy and Standard-of-Care Chemotherapy in People With HPV-Positive Throat Canc
NCT05491512
Memorial Sloan Kettering Cancer CenterPhase 2
UnknownHuman Papilloma Virus Genotypes and Treatment Outcomes of Intralesional Immunotherapy of Anogenital Warts
NCT05761002
Zagazig UniversityN/A
UnknownEvaluation of a Narrative Communication Intervention to Increase Human Papillomavirus Vaccination Intentions a
NCT05352308
Sara FleszarN/A
CompletedIntralesional HPV Vaccine for Condylomata
NCT05087849
University of California, San FranciscoPhase 1 / Phase 2
RecruitingCandida Antigen and Bivalent HPV Vaccine in the Treatment of Multiple Warts
NCT05291845
Zagazig UniversityPhase 2
CompletedImpact Of Intralesional Tuberculin Ppd Injection On Anogenital
NCT07072065
Universitas PadjadjaranPhase 2
RecruitingImpact of Human Papillomavirus Carriage on IVF/ICSI Results (HPV AMP)
NCT06550531
University Hospital, Brest
UnknownCirculating Biomarkers in Patients With Anal Cancer Treated With Induction Chemotherapy
NCT05233540
Aarhus University Hospital
CompletedHealth Belief Model Based Education on Human Papilloma Virus Infection and Vaccination
NCT05175482
Marmara UniversityN/A
UnknownHashtag HPV: HPV Vaccine Twitter Education Program
NCT05204030
University of Arkansas, FayettevilleN/A
UnknownCervical Cancer Screening by Self-sampling in a Cohort of Younger Women in Ethiopia
NCT05125380
Lund UniversityN/A
CompletedERADICATING CERVICAL CANCER IN KENYA
NCT04774887
Indiana UniversityN/A
UnknownSMS Messaging for Invitation in the Cervical Cancer Screening Programme
NCT05362669
Institut Català d'OncologiaN/A
CompletedHPV Vaccine Effectiveness Study in Rwandan Women Living With HIV
NCT05247853
Montefiore Medical Center
CompletedA Proximity-incentive Strategy for Cervical Cancer Screening
NCT04716127
University Hospital, MontpellierN/A
UnknownClinical Evaluation of Detection of High Risk HPV in Urine
NCT05210348
Peking University People's Hospital
UnknownEfficacy of an Intravaginal Treatment With Carboxymethyl-β-glucan and Polycarbophil in HR-HPV Clearance
NCT04781023
Uriach Consumer HealthcareN/A
UnknownEfficacy of Intravaginal Carboxymethyl-β-glucan and Polycarbophil on Low-grade Cervical Lesions (GLUCANCIN)
NCT04771546
Uriach Consumer HealthcareN/A
UnknownA Tailored, Health Communication Intervention for HPV Vaccine Hesitant Families
NCT04380623
Meharry Medical CollegeN/A
WithdrawnInflammation and Co-Infections in D²EFT
NCT04183738
Kirby InstitutePhase 4
CompletedSelf-Testing Options in the Era of Primary HPV Screening for Cervical Cancer Trial
NCT04679675
Kaiser PermanenteN/A
CompletedRelational Agents in Cervical Cancer Education (RACE)
NCT06537687
Radhika GogoiN/A
RecruitingHPV-based Screening Among Women 23-29 Years of Age
NCT05229679
Karolinska InstitutetN/A
CompletedPrevalence of Anal High-risk Human Papilloma Virus Infection and Abnormal Anal Cytology in Men Who Have Sex Wi
NCT04950101
Universitair Ziekenhuis BrusselN/A
RecruitingStudy of 2LPAPI® on the Clearance of Genital HR-HPV Infections.
NCT04232917
Labo'LifePhase 4
RecruitingEducate and Improve Underserved Populations' Uptake and Completion of the HPV Vaccine
NCT04611022
University of Colorado, DenverN/A
CompletedCASUS: Validation for Detection of Precursor Lesions
NCT04530201
Universiteit AntwerpenN/A
CompletedThe Selfie Study- Assessing Novel Markers for Cervical Cancer Screening From Self-collected Samples
NCT04423679
George Washington University
CompletedHPV Vaccination Study in Postpartum Women
NCT04274153
Johns Hopkins UniversityPhase 4
UnknownClinical Validation of Cervical Cancer Screening Methods
NCT04783649
N.N. Petrov National Medical Research Center of Oncology
CompletedVirtual Immersive Communication Training on Recommending Immunizations
NCT04368455
Brittany RosenN/A
UnknownImplementing HPV DNA Self-Collection to Increase Rates of Cervical Cancer Screening in Transgender Men
NCT04154358
Augusta UniversityN/A
Unknown9-valent HPV Vaccine in Postpartum Women
NCT04311528
Augusta UniversityPhase 4
RecruitingStereotactic Boost and Short-course Radiation Therapy for Oropharynx Cancer
NCT04178174
Centre hospitalier de l'Université de Montréal (CHUM)Phase 3
CompletedHuman Papilloma Virus Vaccination and Chronic Inflammatory Rheumatic Diseases.
NCT04180228
Hospices Civils de Lyon
CompletedClinical Trial to Explore Papilocare Gel Efficacy to Repair of the Cervico-vaginal Mucosa With HPV High Risk L
NCT04199078
Procare Health Iberia S.L.N/A
CompletedDe-Escalation Therapy for Human Papillomavirus Negative Disease
NCT03944915
University of ChicagoPhase 2
CompletedAtopic Diseases & Human Papilloma Virus
NCT04397081
Adana Numune Training and Research Hospital
CompletedCASUS: Improved and Quality Assured Collection of First-void Urine
NCT04480866
Universiteit AntwerpenN/A
CompletedGARDASIL 9: 3 Dose vs. 2 Dose With Delayed 3rd Dose
NCT03943875
The University of Texas Medical Branch, GalvestonPhase 4
UnknownIncreasing HPV Immunization Rates: The Rural Adolescent Vaccine Enterprise
NCT03604393
Oregon Health and Science UniversityN/A
UnknownIncreasing HPV Vaccination Rates Via Educational Interventions in Schools Located Within Cedars-Sinai Catchmen
NCT03953911
Cedars-Sinai Medical CenterEARLY_Phase 1
CompletedSDH of HPV Vaccine Completion
NCT03709602
Duke University
CompletedStudy of Topical ABI-1968 in Subjects With Precancerous Cervical Lesions From Human Papillomavirus (HPV) Infec
NCT03697226
Antiva BiosciencesPhase 1
CompletedM7824 in People With Recurrent Respiratory Papillomatosis
NCT03707587
National Cancer Institute (NCI)Phase 2
CompletedHPV Message Testing and Social Media Campaign
NCT03747302
Dartmouth-Hitchcock Medical CenterN/A
UnknownA Cohort Study of Hyperthermia and Imiquimod for the Treatment of Flat Warts
NCT05146895
First Hospital of China Medical UniversityN/A
Active Not RecruitingTORS De-Intensification Protocol Version 2.0: Dose and Volume Reduction in the Neck
NCT03729518
Abramson Cancer Center at Penn MedicineN/A
CompletedIntegrating a Health Information Technology System for Primary and Secondary Cervical Cancer Prevention
NCT03346915
Boston Medical CenterN/A
CompletedInfrared Bioeffect System for the Treatment of Cutaneous Warts
NCT03734003
First Hospital of China Medical UniversityN/A
CompletedHigh and Low Resource Interventions to Promote HPV Vaccines
NCT03824093
Children's Mercy Hospital Kansas CityN/A
CompletedMarketability of a Technology-based Intervention to Increase HPV Vaccination
NCT03497936
Real Prevention, LLCN/A
CompletedIncreasing Human Papillomavirus (HPV) Vaccine Uptake Via General Health Messaging
NCT03759236
University of California, Los AngelesN/A
CompletedStudy of Safety, Tolerability and Immunogenicity of Gardasil®9 in Immunocompromised Patients
NCT03525210
Universitaire Ziekenhuizen KU LeuvenPhase 3
UnknownAirway Intervention Registry (AIR): Recurrent Respiratory Papillomatosis (RRP)
NCT03465280
Newcastle-upon-Tyne Hospitals NHS Trust
CompletedM7824 in Subjects With HPV Associated Malignancies
NCT03427411
National Cancer Institute (NCI)Phase 2
CompletedLocal Hyperthermia for the Treatment of Cervical Intraepithelial Neoplasias
NCT03436251
First Hospital of China Medical UniversityN/A
CompletedStudy of Topical ABI-1968 in Subjects With Precancerous Cervical Lesions From Human Papillomavirus (HPV) Infec
NCT03239223
Antiva BiosciencesPhase 1
UnknownHPV Specific Immune Lymphocytes (HPV-CTLs) in the Treatment of HPV
NCT03351855
Shenzhen Geno-Immune Medical InstitutePhase 1 / Phase 2
CompletedResearch in Ethno-Medicine and Education (REMED)
NCT05907187
University of MiamiN/A
TerminatedZinc Sulfate for Human Papillomavirus (HPV)
NCT03404310
Corewell Health WestN/A
UnknownA Safety and Efficacy Trial of Circumferential Anal Canal Radiofrequency Ablation for High-Grade Anal Intraepi
NCT03302858
Stephen E. GoldstonePhase 2
CompletedSafety and Efficacy of MEDI0457 and Durvalumab in Participants With Human Papilloma Virus (HPV) Associated Rec
NCT03162224
MedImmune LLCPhase 1 / Phase 2
CompletedPreTeenVax Evaluation
NCT03186430
Emory UniversityN/A
CompletedIntra-Anally Administered Artesunate in Patients With High-Grade Anal Intraepithelial Neoplasia (AIN 2/3)
NCT03100045
Johns Hopkins UniversityPhase 1
Active Not RecruitingMen and Women Offering Understanding of Throat HPV
NCT03644563
Johns Hopkins University
UnknownFunctional Outcome After Treatment for Oropharyngeal Squamous Cell Carcinoma
NCT03418909
Rigshospitalet, Denmark
Active Not RecruitingA Dose Reduction Immunobridging and Safety Study of Two HPV Vaccines in Tanzanian Girls
NCT02834637
London School of Hygiene and Tropical MedicinePhase 3
CompletedIncidence of Cervical Cancer in HPV-positive Women With Low-grade Cytological Abnormalities
NCT07259616
Gynaecologisch Oncologisch Centrum Zuid
CompletedComparison of Cervical Pathologies in the Presence of High Risk Hpv Positivity
NCT03895905
Kanuni Sultan Suleyman Training and Research Hospital
CompletedAvelumab for People With Recurrent Respiratory Papillomatosis
NCT02859454
National Cancer Institute (NCI)Phase 2
CompletedCultural Acceptability and Feasibility of HPV Cervical Self Collection Aided by Lay Navigators
NCT03139669
University of VirginiaN/A
CompletedPromoting HPV Vaccine Through Twitter
NCT04023955
Tufts University
CompletedClinical Trial to Explore the Papilocare Gel Efficacy to Repair the Cervico-vaginal Mucosa With Lesions Caused
NCT04002154
Procare Health Iberia S.L.N/A
CompletedHPV Infections, Cancer of the Vulva and Therapeutical Success
NCT03082950
University of Luebeck
WithdrawnAnal Dysplasia Study of Men Who Have Sex With Men Living With HIV
NCT01663558
United States Naval Medical Center, San DiegoPhase 4
CompletedPhase II Evaluation of AHCC for the Eradication of HPV Infections
NCT02405533
The University of Texas Health Science Center, HoustonN/A
UnknownTwo-dose Schedule of Quadrivalent HPV Recombinant Vaccine in 11-year-old Boys in Mexico City
NCT02382900
Universidad Nacional Autonoma de MexicoPhase 3
CompletedCan B12 and Folate Levels Predict HPV Penetration in Patients With ASCUS?
NCT03903952
Sanliurfa Mehmet Akif Inan Education and Research HospitalN/A
CompletedThe Sinai Robotic Surgery Trial in HPV Positive Oropharyngeal Squamous Cell Carcinoma (SCCA) (SIRS TRIAL)
NCT02072148
Icahn School of Medicine at Mount SinaiN/A
UnknownHPV-test, Cervical Cancer and Follow-up
NCT02096016
University of Aarhus
CompletedPhase II Study of HPV Therapeutic Vaccine in HPV Infected Women With Normal Cytology or ASCUS/LSIL
NCT01957878
GenticelPhase 2
CompletedA Multilevel Approach to Increasing HPV Vaccine Initiation Among Adolescents - Part 3
NCT04208269
University of FloridaN/A
CompletedText Reminders to Immunize in a Managed Care Organization
NCT01806714
University of RochesterN/A
CompletedAt-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurolo
NCT01931644
Sanguine Biosciences
CompletedPromoting Human Papillomavirus (HPV) Vaccination Through African American Beauty Salons
NCT01461408
MEE Productions, Inc.N/A
CompletedCandin Safety & Efficacy Study for the Treatment of Warts
NCT01757392
Nielsen BioSciences, Inc.Phase 2
UnknownPrevaccination Study of Cervical Human Papillomavirus Types in Yangtze River Delta Area, China
NCT01487681
Xing Xie, MD
TerminatedDocetaxel/Cisplatin/5-Fluorouracil (TPF) Human Papillomavirus (HPV) Squamous Cell Carcinoma Study
NCT01221753
Dana-Farber Cancer InstitutePhase 2
CompletedHuman Papillomatosis Genotyping of Children in Thailand
NCT01304966
Queen Sirikit National Institute of Child Health
CompletedTyping of Human Papilloma Virus (HPV) From Female Genital Warts
NCT01192282
University of Cape Town
CompletedAcceptance of Human Papillomavirus Vaccination in Postpartum Women
NCT00730704
Columbia University
CompletedBroad Spectrum HPV Vaccine Dose Escalation Study (V502-002)
NCT00851643
Merck Sharp & Dohme LLCPhase 1